6
Clinical Trials associated with Influenza Vaccine (Split Virion),Inactivated,Quadrivalent(Jiangsu Jindike Biotechnology Co., Ltd.)A Clinical Trial to Assess Immunogencity and Safety of 2 Doses of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For those aged 6 months through 8 years who have previously received ≥2 total doses of trivalent or quadrivalent influenza vaccine ≥4 weeks apart, they require only 1 dose of influenza vaccine. For those who have not previously received ≥2 doses of trivalent or quadrivalent influenza vaccine, they require 2 dose of influenza vaccine. but the evidence on how to select vaccine doses for quadrivalent influenza vaccine is limited in China. The study is a prospective, open-label comparison of the immunogenicity and reactogenicity of 1 versus 2 doses of an inactivated quadrivalent influenza vaccine in subjects of 3-8 years old with different history of influenza vaccination.
四价流感病毒裂解疫苗在6-35月龄健康受试者中的单中心、剂量递增、开放设计的I期临床试验
[Translation] A single-center, dose-escalation, open-label phase I clinical trial of a quadrivalent influenza virus split vaccine in healthy subjects aged 6-35 months
评价江苏金迪克生物技术有限公司研制的四价流感病毒裂解疫苗在6-35月龄健康受试者中不同剂量的耐受性和安全性,初步探索免疫原性。
[Translation] To evaluate the tolerability and safety of different doses of the quadrivalent influenza virus split vaccine developed by Jiangsu Jindik Biotechnology Co., Ltd. in healthy subjects aged 6-35 months, and preliminarily explore the immunogenicity.
在满3周岁以上健康人群中开展的流感病毒裂解疫苗(四价)随机、双盲、阳性对照、非劣效设计的Ⅲ期临床试验
[Translation] A randomized, double-blind, positive-controlled, non-inferiority designed Phase III clinical trial of influenza virus split vaccine (quadrivalent) in healthy people aged 3 years and above
评价江苏金迪克生物技术有限公司研制的流感病毒裂解疫苗(四价)在满3周岁以上健康人群中接种的免疫原性和安全性。
[Translation] To evaluate the immunogenicity and safety of the influenza virus split vaccine (quadrivalent) developed by Jiangsu Jindik Biotechnology Co., Ltd. in healthy people aged 3 years and above.
100 Clinical Results associated with Influenza Vaccine (Split Virion),Inactivated,Quadrivalent(Jiangsu Jindike Biotechnology Co., Ltd.)
100 Translational Medicine associated with Influenza Vaccine (Split Virion),Inactivated,Quadrivalent(Jiangsu Jindike Biotechnology Co., Ltd.)
100 Patents (Medical) associated with Influenza Vaccine (Split Virion),Inactivated,Quadrivalent(Jiangsu Jindike Biotechnology Co., Ltd.)
100 Deals associated with Influenza Vaccine (Split Virion),Inactivated,Quadrivalent(Jiangsu Jindike Biotechnology Co., Ltd.)